Duncker Streett & CO Inc Viatris Inc Transaction History

Duncker Streett & CO Inc

$542 Million
Q3 2024

A detailed history of Duncker Streett & CO Inc transactions in Viatris Inc stock. As of the latest transaction made, Duncker Streett & CO Inc holds 1,638 shares of VTRS stock, worth $20,507. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,638

Previous 1,554 5.41%

Holding current value

$20,507

Previous $16,000 18.75%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.32 - $12.13 $866 - $1,018	84 Added 5.41%	1,638 $19,000
Q2 2024 Jul 31, 2024	BUY	$10.05 - $12.02 $20 - $24	2 Added 0.13%	1,554 $16,000
Q1 2024 Apr 23, 2024	SELL	$11.27 - $13.53 $1,611 - $1,934	-143 Reduced 8.44%	1,552 $18,000
Q4 2023 Jan 30, 2024	SELL	$8.77 - $10.85 $1,078 - $1,334	-123 Reduced 6.77%	1,695 $18,000
Q2 2023 Jul 20, 2023	SELL	$9.02 - $10.29 $11,509 - $13,130	-1,276 Reduced 41.24%	1,818 $18,000
Q3 2022 Nov 04, 2022	SELL	$8.48 - $11.13 $67 - $89	-8 Reduced 0.26%	3,094 $26,000
Q2 2022 Aug 04, 2022	SELL	$9.95 - $12.27 $119 - $147	-12 Reduced 0.39%	3,102 $32,000
Q1 2022 May 09, 2022	SELL	$9.81 - $15.4 $4,649 - $7,299	-474 Reduced 13.21%	3,114 $34,000
Q4 2021 Feb 08, 2022	SELL	$12.09 - $14.68 $9,889 - $12,008	-818 Reduced 18.57%	3,588 $49,000
Q3 2021 Nov 03, 2021	BUY	$13.25 - $15.13 $4,929 - $5,628	372 Added 9.22%	4,406 $60,000
Q2 2021 Jul 27, 2021	BUY	$12.97 - $16.15 $5,175 - $6,443	399 Added 10.98%	4,034 $58,000
Q1 2021 Apr 28, 2021	SELL	$13.59 - $18.54 $42,849 - $58,456	-3,153 Reduced 46.45%	3,635 $51,000
Q4 2020 Feb 02, 2021	BUY	$14.3 - $18.74 $97,068 - $127,207	6,788 New	6,788 $127,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Duncker Streett & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Duncker Streett & CO Inc with notifications on news.

Account

Duncker Streett & CO Inc Viatris Inc Transaction History